According to the National Cancer Institute, prostate cancer is the most common male cancer and the second leading cause of cancer deaths in men. The standard treatment for prostate cancer is removal of the prostate gland through surgery. Open surgery involves up to an eight-inch incision below the navel to remove the prostate and a portion of the urethra.
Hahnemann University Hospital now provides an alternative new treatment option with minimally invasive surgical technique known as laparoscopic radical prostatectomy. The advance is made possible by combining surgeon skill with an integrated computer visualization and robotic assistance system. The da Vinci® system’s precise, small incisions result in less bleeding, decreased pain, and quicker recovery times. Patient results are encouraging with sexual potency and continence potentially returning more rapidly than with standard prostate surgery. Our minimally invasive urologic robotic surgical team of Dr. Jamison Jaffe, Dr. Justin Harmon, and Dr. Erica Lambert [Learn more about these physicians] were specially trained in this advanced procedure.
Other treatment options available at Hahnemann for patients with prostate cancer include:
Terms And Conditions
Notice of Privacy Practices
Hahnemann University Hospital | 230 N Broad St, Philadelphia, PA 19102
© 2002-2014 Tenet HealthSystem Hahnemann, LLC, All Rights Reserved.